Academic Journal
The estimated health impact of sodium reduction through food reformulation in Australia: A modeling study.
| Title: | The estimated health impact of sodium reduction through food reformulation in Australia: A modeling study. |
|---|---|
| Authors: | Kathy Trieu, Daisy H Coyle, Ashkan Afshin, Bruce Neal, Matti Marklund, Jason H Y Wu |
| Source: | PLoS Medicine, Vol 18, Iss 10, p e1003806 (2021) |
| Publisher Information: | Public Library of Science (PLoS), 2021. |
| Publication Year: | 2021 |
| Collection: | LCC:Medicine |
| Subject Terms: | Medicine |
| More Details: | BackgroundThe Australian Government recently established sodium targets for packaged foods to encourage voluntary reformulation to reduce population sodium consumption and related diseases. We modeled the health impact of Australia's sodium reformulation targets and additional likely health gains if more ambitious, yet feasible sodium targets had been adopted instead.Methods and findingsUsing comparative risk assessment models, we estimated the averted deaths, incidence, and disability-adjusted life years (DALYs) from cardiovascular disease (CVD), chronic kidney disease (CKD) and stomach cancer after implementation of (a) Australia's sodium targets (overall and by individual companies); (b) United Kingdom's targets (that covers more product categories); and (c) an optimistic scenario (sales-weighted 25th percentile sodium content for each food category included in the UK program). We used nationally representative data to estimate pre- and post-intervention sodium intake, and other key data sources from the Global Burden of Disease study. Full compliance with the Australian government's sodium targets could prevent approximately 510 deaths/year (95% UI, 335 to 757), corresponding to about 1% of CVD, CKD, and stomach cancer deaths, and prevent some 1,920 (1,274 to 2,600) new cases and 7,240 (5,138 to 10,008) DALYs/year attributable to these diseases. Over half (59%) of deaths prevented is attributed to reformulation by 5 market-dominant companies. Compliance with the UK and optimistic scenario could avert approximately an additional 660 (207 to 1,227) and 1,070 (511 to 1,856) deaths/year, respectively, compared to Australia's targets. The main limitation of this study (like other modeling studies) is that it does not prove that sodium reformulation programs will prevent deaths and disease events; rather, it provides the best quantitative estimates and the corresponding uncertainty of the potential effect of the different programs to guide the design of policies.ConclusionsThere is significant potential to strengthen Australia's sodium reformulation targets to improve its health impact. Promoting compliance by market-dominant food companies will be critical to achieving the potential health gains. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 1549-1277 1549-1676 40990257 |
| Relation: | https://doaj.org/toc/1549-1277; https://doaj.org/toc/1549-1676 |
| DOI: | 10.1371/journal.pmed.1003806 |
| Access URL: | https://doaj.org/article/40990257e34e4285afff370520a1e733 |
| Accession Number: | edsdoj.40990257e34e4285afff370520a1e733 |
| Database: | Directory of Open Access Journals |
| Full text is not displayed to guests. | Login for full access. |
| ISSN: | 15491277 15491676 40990257 |
|---|---|
| DOI: | 10.1371/journal.pmed.1003806 |
| Published in: | PLoS Medicine |
| Language: | English |